Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses

Clinical trial NCT00777127 · COMPLETED

Trial details

NCT number: NCT00777127
Sponsor: MEDA Pharma GmbH & Co. KG
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2008-12-01
Primary completion: 2012-11-01
Enrollment: 258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.